Back

Effects of transition programs to adulthood for adolescents and young adults with congenital heart disease: a systematic review with meta-analysis

Lee, B. R.; Koo, H. Y.; Lee, S.

2023-09-12 cardiovascular medicine
10.1101/2023.09.11.23295387 medRxiv
Show abstract

BACKGROUNDThe increased survival rate among individuals with congenital heart disease (CHD) has sparked interest in their transition to adult healthcare. Although there is a general agreement on the importance of transition interventions, the empirical evidence supporting them is insufficient. Therefore, this study aimed to conduct a systematic review and meta-analysis of transition interventions for adult healthcare in adolescents and young adults. METHODS AND RESULTSA literature search was conducted for studies comparing the quantitative effects of transition interventions with control groups, published up to March 15, 2023, in major databases (CENTRAL, Embase, PubMed, Web of Science, CINAHL, KISS, and KMbase), major clinical trial registers, academic journal sites related to the topic, and grey literature databases. Ten studies involving a total of 1,297 participants were identified. Transition interventions proved effective in enhancing disease-related knowledge (Hedges g=0.89, 95% CI=0.29-1.48) and self-management (Hedges g=0.67, 95% CI=0.38-0.95), as well as reducing loss to follow-up (OR=0.41, 95% CI=0.22-0.77). The certainty of evidence for the estimated values of each major outcome was low or very low. CONCLUSIONSThis study supports the implementation of transition interventions by demonstrating that they can improve patients disease knowledge and self-management, while also promoting treatment continuity. However, since the available data on transition interventions for adolescents and young adults with CHD remain limited, the widespread adoption of structured transition interventions in the future may alter the conclusions of this study. REGISTRATIONURL: https://www.crd.york.ac.uk/PROSPERO. Unique identifier: CRD42023399026. CLINICAL PERSPECTIVEO_ST_ABSWhat Is New?C_ST_ABSO_LIThis systematic review of transition programs for individuals of transitional age with congenital heart disease identified 10 relevant studies. C_LIO_LITransition programs for adolescents and young adults with congenital heart disease were primarily designed to provide individual education, supplement roles related to anatomical and hemodynamic considerations, manage medications and medical appointments and facilitate communication with healthcare providers. C_LIO_LIThe transition programs demonstrated efficacy in enhancing disease-related knowledge and self-management, as well as in reducing instances of loss to follow-up. However, they did not significantly improve disease-related quality of life. C_LI What Are the Clinical Implications?O_LIGiven the ethical and practical considerations that arise from country-specific conditions and environments, research on congenital heart disease transition programs should utilize a feasible study design that incorporates a control group. C_LIO_LITransition programs should address lifestyle factors that can enhance heart function and alleviate clinical symptoms. After promoting long-term commitment to these programs, it is necessary to assess the effects on disease-related quality of life. C_LIO_LIAn execution of a transition program that takes into account the developmental characteristics of the target age group, as well as a transition program involving parents, is necessary. Subsequently, an analysis of the effects of these programs is also required. C_LIO_LIAs a result of the transition program, it is necessary to measure and analyze not only process indicators but also outcome indicators that directly reflect an individuals health (e.g. emergency room visits, hospital admissions, and the status of disease or complications). C_LI

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Open Heart
19 papers in training set
Top 0.1%
26.8%
2
Heart
10 papers in training set
Top 0.1%
10.8%
3
Journal of the American Heart Association
119 papers in training set
Top 0.8%
8.7%
4
BMJ Open
554 papers in training set
Top 3%
7.4%
50% of probability mass above
5
PLOS ONE
4510 papers in training set
Top 30%
5.0%
6
The American Journal of Cardiology
15 papers in training set
Top 0.4%
5.0%
7
Journal of Clinical Medicine
91 papers in training set
Top 1%
3.7%
8
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 1%
2.8%
9
European Journal of Preventive Cardiology
13 papers in training set
Top 0.3%
2.7%
10
Circulation
66 papers in training set
Top 1%
2.4%
11
Journal of the American College of Cardiology
12 papers in training set
Top 0.3%
1.8%
12
BMC Cardiovascular Disorders
14 papers in training set
Top 0.9%
1.8%
13
BMC Medicine
163 papers in training set
Top 4%
1.5%
14
Circulation: Heart Failure
14 papers in training set
Top 0.3%
1.4%
15
Scientific Reports
3102 papers in training set
Top 65%
1.3%
16
BMJ
49 papers in training set
Top 0.8%
1.3%
17
European Heart Journal
16 papers in training set
Top 0.6%
1.0%
18
Circulation: Genomic and Precision Medicine
42 papers in training set
Top 1.0%
1.0%
19
Trials
25 papers in training set
Top 1%
0.9%
20
PLOS Medicine
98 papers in training set
Top 4%
0.8%
21
European Heart Journal - Digital Health
15 papers in training set
Top 0.6%
0.7%
22
Pilot and Feasibility Studies
12 papers in training set
Top 0.8%
0.5%
23
Healthcare
16 papers in training set
Top 2%
0.5%
24
BJGP Open
12 papers in training set
Top 0.8%
0.5%
25
JMIR Research Protocols
18 papers in training set
Top 2%
0.5%
26
Vaccine
189 papers in training set
Top 2%
0.5%